PRKDC and familial pancreatic carcinoma: Additionally, inhibition of DNA-dependent protein kinase (DNA-PK) has been shown to synergize with radiotherapy and modulate the immune system in pancreatic cancer models by increasing cytosolic double-stranded DNA and type 1 interferon signaling.